Free Trial

Evergreen Capital Management LLC Cuts Holdings in Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background

Key Points

  • Evergreen Capital Management LLC reduced its stake in Synopsys, Inc. by 26.7%, bringing its ownership down to 1,420 shares valued at approximately $609,000 as of the latest SEC filing.
  • Several institutional investors have increased their holdings in Synopsys, with notable increases from The Manufacturers Life Insurance Company, Canada Pension Plan Investment Board, and Parnassus Investments LLC.
  • Analysts maintain a positive outlook for Synopsys, with Needham & Company reaffirming a "buy" rating and increasing the price target to $660, while the average price target among analysts is currently around $634.64.
  • MarketBeat previews top five stocks to own in October.

Evergreen Capital Management LLC decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 26.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,420 shares of the semiconductor company's stock after selling 517 shares during the period. Evergreen Capital Management LLC's holdings in Synopsys were worth $609,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. The Manufacturers Life Insurance Company grew its position in shares of Synopsys by 2.8% during the first quarter. The Manufacturers Life Insurance Company now owns 137,382 shares of the semiconductor company's stock valued at $58,935,000 after purchasing an additional 3,704 shares in the last quarter. Canada Pension Plan Investment Board grew its position in shares of Synopsys by 18.1% during the first quarter. Canada Pension Plan Investment Board now owns 53,039 shares of the semiconductor company's stock valued at $22,746,000 after purchasing an additional 8,130 shares in the last quarter. Parnassus Investments LLC grew its position in shares of Synopsys by 15.5% during the first quarter. Parnassus Investments LLC now owns 1,363,310 shares of the semiconductor company's stock valued at $584,655,000 after purchasing an additional 182,642 shares in the last quarter. WPG Advisers LLC purchased a new position in shares of Synopsys during the first quarter valued at about $34,000. Finally, Landscape Capital Management L.L.C. purchased a new position in shares of Synopsys during the first quarter valued at about $1,450,000. Hedge funds and other institutional investors own 85.47% of the company's stock.

Synopsys Stock Down 1.4%

Shares of NASDAQ SNPS opened at $603.52 on Monday. The company has a debt-to-equity ratio of 1.01, a current ratio of 7.02 and a quick ratio of 6.85. The company has a market cap of $93.64 billion, a P/E ratio of 43.58, a PEG ratio of 3.97 and a beta of 1.14. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The firm has a 50-day simple moving average of $583.07 and a two-hundred day simple moving average of $503.25.

Analysts Set New Price Targets

SNPS has been the subject of a number of research analyst reports. Needham & Company LLC restated a "buy" rating and set a $660.00 price objective (up previously from $650.00) on shares of Synopsys in a research report on Tuesday, July 15th. The Goldman Sachs Group began coverage on shares of Synopsys in a report on Thursday, July 10th. They issued a "buy" rating and a $620.00 price target for the company. Wells Fargo & Company reaffirmed a "positive" rating on shares of Synopsys in a report on Wednesday. KeyCorp increased their price target on shares of Synopsys from $540.00 to $610.00 and gave the company an "overweight" rating in a report on Thursday, July 10th. Finally, Bank of America increased their price target on shares of Synopsys from $575.00 to $625.00 and gave the company a "buy" rating in a report on Wednesday, July 16th. Twelve analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $634.64.

Read Our Latest Stock Report on Synopsys

Insider Activity

In other Synopsys news, CFO Shelagh Glaser sold 7,310 shares of the firm's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $485.72, for a total value of $3,550,613.20. Following the completion of the sale, the chief financial officer owned 15,291 shares of the company's stock, valued at $7,427,144.52. This trade represents a 32.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CRO Richard S. Mahoney sold 9,010 shares of the firm's stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the completion of the sale, the executive directly owned 1,485 shares of the company's stock, valued at approximately $699,746.85. The trade was a 85.85% decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is owned by company insiders.

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Further Reading

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines